|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:alsoKnownAs
|
gptkb:aminosidine
gptkb:paromomycin
|
|
gptkbp:ATCCode
|
gptkb:A07AA06
|
|
gptkbp:CASNumber
|
7542-37-2
|
|
gptkbp:chemicalFormula
|
C23H45N5O13
|
|
gptkbp:contraindication
|
intestinal obstruction
|
|
gptkbp:discoveredBy
|
gptkb:Herbert_E._Carter
|
|
gptkbp:discoveredIn
|
1956
|
|
gptkbp:drugClass
|
gptkb:antibiotic
|
|
gptkbp:foundIn
|
gptkb:Streptomyces_rimosus
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Paromycin
|
|
gptkbp:KEGGID
|
D08367
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits protein synthesis by binding to 16S rRNA of the 30S ribosomal subunit
|
|
gptkbp:MedlinePlusID
|
a682282
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
441375
CHEMBL1201207
DB01421
|
|
gptkbp:routeOfAdministration
|
oral
topical
|
|
gptkbp:sideEffect
|
nausea
diarrhea
nephrotoxicity
abdominal cramps
ototoxicity
|
|
gptkbp:UNII
|
T2V3J8G1X9
|
|
gptkbp:usedFor
|
leishmaniasis
amebiasis
giardiasis
intestinal tapeworm infection
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:paromomycin
|
|
gptkbp:bfsLayer
|
6
|